In the News | Friends of Cancer Research

You are here

In the News

January 15, 2019
Cancer patients with high tumor mutational burden who were treated with immunotherapy tended to live longer than those with fewer mutations, researchers at Memorial Sloan Kettering Cancer Center... Read more
January 15, 2019
Patients diagnosed with cancer who also have other illnesses or conditions, such as hypertension, asthma, or a prior cancer, are less likely to talk with their health-care provider about a cancer... Read more
January 15, 2019
Clinical trial participation is crucial for drug development, but it’s estimated that just 5% of patients participate in clinical trials. While institutional factors, such as lack of a locally... Read more
January 14, 2019
As efforts are being made to improve enrollment in cancer trials, a new study found that physicians were less likely to even discuss or offer clinical trial participation when patients had... Read more
January 14, 2019
Experiments involving just a few patients have hinted at it, and research on one type of tumor at a time has supported it, but a large study has now delivered the strongest evidence yet about how to... Read more
January 10, 2019
Patients with cancer and comorbidities are routinely left out of clinical trial discussions, offers and participation, according to results of a study published in JAMA Oncology.   At least 60% of... Read more
January 10, 2019
How do you make cancer clinical trials available to more patients?   A new study published today in JAMA Oncology and led by Dr. Joseph Unger at Fred Hutchinson Cancer Research Center offers a... Read more
January 8, 2019
Executive Summary Agency staff discuss how they offer early development advice to sponsors before a breakthrough decision is made and reassure them if the status is denied.   Sponsors may desire... Read more
January 3, 2019
Executive Summary Siding with coalition of hospitals, judge ruled that HHS lacked authority to cut Medicare reimbursement for drugs purchased at 340B prices. That should change the dynamics of the... Read more
January 2, 2019
Executive Summary Synthetic control group derived from historical clinical trial data could augment smaller randomized trials and yield better information than single-arm studies, but this approach... Read more

Pages